3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel-

Request For Quotation
3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- manufacturers

  • DRP1i27
  • DRP1i27 pictures
  • $2370.00
  • 2026-07-15
  • CAS:1453028-33-5
  • Purity:
  • Supply Ability: 10g
3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Basic information
Product Name:3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel-
Synonyms:3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel-;DRP1i27
CAS:1453028-33-5
MF:C20H26N6O
MW:366.46
EINECS:
Product Categories:
Mol File:1453028-33-5.mol
3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Structure
3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Chemical Properties
Boiling point 618.5±50.0 °C(Predicted)
density 1.277±0.06 g/cm3(Predicted)
form Solid
pka13.31±0.10(Predicted)
color Light yellow to brown
Safety Information
MSDS Information
3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Usage And Synthesis
UsesDRP1i27 is a potent inhibitor of human Drp1 (dynamin-related protein 1). DRP1i27 binds to the GTPase site of Drp1, with hydrogen bonds to Gln34 and Asp218. DRP1i27 targets Drp1-mediated mitochondrial fission in cell line models and protects against simulated ischemia-reperfusion injury[1].
References[1] Rosdah AA, et al. A novel small molecule inhibitor of human Drp1. Sci Rep. 2022 Dec 13;12(1):21531. DOI:10.1038/s41598-022-25464-z
3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Preparation Products And Raw materials
Tag:3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel-(1453028-33-5) Related Product Information
DRP1i27 dihydrochloride 3,6-Diazabicyclo[3.2.2]nonane, 3-[(4-methyl-1H-imidazol-5-yl)methyl]-6-[[5-(1H-pyrazol-3-yl)-2-furanyl]methyl]-, (1R,5S)-rel- Dynasore Acetamide, 2-chloro-N-methyl-N-[3-(10H-phenothiazin-10-yl)propyl]- 1H-Indole-3-methanamine, N-decyl-1-[3-(dimethylamino)propyl]- IR783